A Phase II Trial of Neoadjuvant Dasatinib (Neo-D) in Muscle-Invasive Urothelial Carcinoma of the Bladder (miucb): Hoosier Oncology Group GU07-122 Trial.
Journal of clinical oncology(2012)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of clinical oncology(2012)